Narinder Singh Shargill, PhD, is vice president of global medical affairs at Pulmonx, bringing over 30 years of experience advancing medical devices through clinical development, regulatory approval and postmarket support — including more than 20 years in interventional pulmonology. He previously held leadership roles at Boston Scientific, Asthmatx and Baxter, and played a key role in securing U.S. Food and Drug Administration approval for the Zephyr Valves.